Table 3.
Association of creatinine-corrected log10 prenatal OP metabolite levels and 24-month MDI and PDI considering heterogeneity by center.
Model | CHAMACOS [β per 10-fold increase (95% CI)]a | HOME [β per 10-fold increase (95% CI)]a | Columbia [β per 10-fold increase (95% CI)]a | Mount Sinai [β per 10-fold increase (95% CI)]a | Center-OP-interaction (p-value)a | Pooled [β per 10-fold increase (95% CI)]a | Pooled (extended model) [β per 10-fold increase (95% CI)]b |
---|---|---|---|---|---|---|---|
24-month MDI | n = 366 | n = 257 | n = 53 | n = 225 | n = 901 | n = 901 | n = 890 |
Log10 ∑DAP (nmol/gC) | –4.17 (–7.00, –1.33) | 0.97 (–1.82, 3.76) | –0.79 (–4.17, 2.59) | –1.14 (–3.12, 0.84) | 0.09 | –1.28 (–2.58, 0.03) | –1.48 (–2.77, –0.19) |
Log10 ∑DEP (nmol/gC) | –1.40 (–4.12, 1.32) | –1.10 (–3.42, 1.22) | 0.11 (–2.88, 3.11) | –0.22 (–1.85, 1.42) | 0.81 | –0.57 (–1.69, 0.54) | –0.82 (–1.93, 0.28) |
Log10 ∑DMP (nmol/gC) | –3.64 (–5.97, –1.32) | 0.73 (–1.59, 3.04) | 0.13 (–2.33, 2.58) | –0.80 (–2.52, 0.91) | 0.05 | –0.91 (–1.98, 0.16) | –1.06 (–2.12, 0.00) |
24-month PDI | n = 368 | n = 258 | n = 55 | n = 228 | n = 909 | n = 909 | n = 898 |
Log10 ∑DAP (nmol/gC) | –1.35 (–4.10, 1.41) | 1.09 (–1.63, 3.80) | –0.39 (–3.67, 2.90) | –0.27 (–2.17, 1.63) | 0.67 | –0.23 (–1.48, 1.03) | –0.08 (–1.34, 1.18) |
Log10 ∑DEP (nmol/gC) | –0.91 (–3.54, 1.72) | –0.32 (–2.57, 1.93) | –0.35 (–3.13, 2.42) | 0.52 (–1.03, 2.06) | 0.79 | –0.02 (–1.09, 1.04) | 0.15 (–0.91, 1.22) |
Log10 ∑DMP (nmol/gC) | –1.29 (–3.56, 0.97) | 0.83 (–1.41, 3.08) | –0.42 (–2.79, 1.95) | –0.45 (–2.11, 1.21) | 0.63 | –0.35 (–1.39, 0.68) | –0.30 (–1.34, 0.73) |
∑DAP = ∑DEP + ∑DMP. aModels were adjusted for maternal education, marital status, and age at delivery, alcohol use during pregnancy, child sex, Home environment score quartile, and breastfeeding at least 3 months after birth, and include metabolite × center interaction terms. Tests for interaction were calculated using F-tests with 3 degrees of freedom. bAdditionally adjusted for race/ethnicity, smoking and drug use during pregnancy. |